Fortrea Holdings (FTRE) Non-Current Deferred Tax Liability (2022 - 2026)

Fortrea Holdings (FTRE) reported Non-Current Deferred Tax Liability of $92.3 million for Q1 2026, down 21.71% on a YoY basis from $117.9 million in Q1 2025, and down 5.43% quarter-over-quarter from $97.6 million in Q4 2025.

Fortrea Holdings (FTRE) Non-Current Deferred Tax Liability (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Non-Current Deferred Tax Liability for 5 years, with the latest figure at $92.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 21.71% year-over-year to $92.3 million; the trailing twelve-month figure through Mar 2026 stood at $92.3 million (down 21.71% YoY), and the FY2025 full-year result was $97.6 million, down 19.8% from the prior year.
  • Non-Current Deferred Tax Liability for Q1 2026 stood at $92.3 million, down from $97.6 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $184.5 million in Q4 2022, with the low at $92.3 million in Q1 2026.
  • Historically, Non-Current Deferred Tax Liability has averaged $134.7 million across 5 years, with a median of $126.9 million in 2024.
  • Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability decreased 26.11% — and 2025, when it dropped 15.76%.
  • Fortrea Holdings' Non-Current Deferred Tax Liability stood at $184.5 million in 2022, then dropped by 19.95% to $147.7 million in 2023, then fell by 17.6% to $121.7 million in 2024, then fell by 19.8% to $97.6 million in 2025, then declined by 5.43% to $92.3 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $92.3 million (Q1 2026), $97.6 million (Q4 2025), and $106.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 92.30 Mn
Mar 31, 2026 92.30 Mn
Dec 31, 2025 97.60 Mn
Dec 31, 2025 97.60 Mn
Sep 30, 2025 106.90 Mn
Sep 30, 2025 106.90 Mn
Jun 30, 2025 112.80 Mn
Jun 30, 2025 112.80 Mn
Mar 31, 2025 117.90 Mn
Mar 31, 2025 117.90 Mn
Dec 31, 2024 121.70 Mn
Dec 31, 2024 121.70 Mn
Sep 30, 2024 126.90 Mn
Sep 30, 2024 126.90 Mn
Jun 30, 2024 136.10 Mn
Jun 30, 2024 136.10 Mn
Mar 31, 2024 150.70 Mn
Mar 31, 2024 150.70 Mn
Dec 31, 2023 147.70 Mn
Dec 31, 2023 147.70 Mn